Cue Biopharma (CUE) Research & Development (2017 - 2025)
Cue Biopharma (CUE) has disclosed Research & Development for 9 consecutive years, with $16.5 million as the latest value for Q4 2025.
- Quarterly Research & Development rose 130.12% to $16.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.7 million through Dec 2025, up 3.99% year-over-year, with the annual reading at $37.7 million for FY2025, 3.99% up from the prior year.
- Research & Development hit $16.5 million in Q4 2025 for Cue Biopharma, up from $4.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $16.5 million in Q4 2025 to a low of $4.8 million in Q3 2025.
- Historically, Research & Development has averaged $9.7 million across 5 years, with a median of $9.7 million in 2021.
- Biggest YoY gain for Research & Development was 130.12% in 2025; the steepest drop was 49.32% in 2025.
- Year by year, Research & Development stood at $11.5 million in 2021, then fell by 1.47% to $11.3 million in 2022, then dropped by 3.93% to $10.9 million in 2023, then crashed by 34.01% to $7.2 million in 2024, then skyrocketed by 130.12% to $16.5 million in 2025.
- Business Quant data shows Research & Development for CUE at $16.5 million in Q4 2025, $4.8 million in Q3 2025, and $7.9 million in Q2 2025.